Skip to main content

Table 2 Contingency table showing test results of rebiopsy and plasma ddPCR for EGFR T790M mutation (N = 53)

From: Monitoring of T790M in plasma ctDNA of advanced EGFR-mutant NSCLC patients on first- or second-generation tyrosine kinase inhibitors

 

Rebiopsy T790M

ddPCR T790M

Positive

Negative

Positive

19 (36)

4 (8)

Negative

9 (17)

21 (40)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us